AllDocs -> heart diseases

Printer Friendly If you wish to unsubscribe from any eDocAmerica mailings, please click on the image above. Register Now If you have not yet used eDocAmerica to communicate with our physicians, we urge you to give Health Tip: Hypertension in children and adolescents, a growing concern In adults, most high blood pressure is known as "essential" or primary hypertension , meaning that there is no underlying "disease" responsible for the blood pressure elevation. Primary hypertension may be due to hereditary influences or is sometimes considered to be a "disease of lifestyle", related to factors such as excessive sodium intake, lack of exercise or being overweight. Historically, children have been more likely to have "secondary" hypertension , meaning that the blood pressure elevation is associated with an underlying disease such as kidney or endocrine problems. ...

doi:10.1136/bmj.328.7440.634 2004;328;634-640 BMJ McInnes, John F Potter, Peter S Sever and Simon McG Thom Bryan Williams, Neil R Poulter, Morris J Brown, Mark Davis, Gordon T summary hypertension management 2004 (BHS-IV): British Hypertension Society guidelines for http://bmj.com/cgi/content/full/328/7440/634 Updated information and services can be found at: These include: Data supplement http://bmj.com/cgi/content/full/328/7440/634/DC1 "Categories of strength used in statements" References http://bmj.com/cgi/content/full/328/7440/634#otherarticles 29 online articles that cite this article can be accessed at: http://bmj.com/cgi/content/full/328/7440/634#BIBL This article cites 22 articles, 7 of which can be accessed free at: Rapid responses http://bmj.com/cgi/eletter-submit/328/7440/634 ...

Title : Perioperative Nitroglycerin in a Patient with Pulmonary Hypertension Refractory to Nitric Oxide Therapy Authors : Thom, Jeremy, MD, Kinane, P., MD, Chang, T.Y., MD, Chen, S., Riad, M., MD, Mogos, M., MD, Roffey, P., MD and D. Thangathurai, MD. Introduction : A patient with severe pulmonary hypertension presented as high risk for anesthesia management during major surgery. Pulmonary hypertension can result from a variety of causes such as mitral valve disease, pulmonary disease, hypoxemia, and from other unknown causes. Nitric oxide, an inhaled pulmonary vasodilator, appears to be an ideal treatment to lower pulmonary artery pressures during the perioperative period. We are reporting the perioperative management of a patient with pulmonary hypertension resistant to nitric oxide who responded favorably to intravenous nitroglycerin. Case Study : A 52 year old morbidly obese female patient ...

Title : Perioperative Management of Severe Pulmonary Hypertension with Inhaled Nitric Oxide and Oral Sildenafil (Viagra TM ) During Orthotopic Liver Transplantation. Case Presentation. Authors : Angel Jose deLeon Vaca, M.D.†, Earl M. Strum, M.D.†, Janos Szenohradszki, M.D. Ph.D.†, Linda Sher, M.D.‡, Robert Selby, M.D.‡ Affiliation : Departments of Anesthesiology † and Surgery ‡, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033 Introduction: Pulmonary hypertension (PHT) is a life-threatening disease leading to right heart failure. It often occurs along with cirrhosis (hepatopulmonary syndrome), which often necessitates liver transplantation. The combination of inhaled nitric oxide (iNO) and oral sildenafil, a phosphodiesterase-5 inhibitor, has been used recently (2000- 2005) to treat severe PHT. 1,2 We diagnosed severe ...

Part II: Treatment of Essential Hypertension Scope This guideline focuses on the treatment of essential hypertension (HT) in non-pregnant adults (aged 19 years and older). This guideline is to be used with “Part I: Detection and Diagnosis of Hypertension ”. R ECOMMENDATION 1: Standard of care • In the course of normal medical contact, people should have their blood pressure recorded once every two to five years commensurate with age. • Establish firm diagnosis and rule out underlying causes. • Identify those requiring immediate management. • Establish the patient’s role in managing their condition, review lifestyle modifications. • Establish the minimum dose of medication required to achieve the target BP (see table 1). Table 1: Blood pressure treatment targets * † * The benefits of initiating antihypertensive therapy when hypertension is first diagnosed after ...

HYPERTENSION ENCOUNTER FORM - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - c ontinued ? Patient’s name: __ Age: Weight: __ Height: __ BMI (over): HISTORY OF PRESENT ILLNESS Loud snoring, obesity, gasping and daytime sleepiness (sleep apnea) Headache, sweating and palpitations (pheochromocytoma) Major risk factors (check if present) Target-organ damage (check if present) Hypertension Tobacco use Obesity (BMI = 30 kg per m 2 ) Physical inactivity Dyslipidemia Diabetes mellitus Microalbuminuria or glomerular filtration rate < 60 mL per minute Age > 55 years (men) or > 65 years (women) Family history of premature cardiovascular disease ...

Please visit Journal of Hypertension online at: http://jhypertension.com F OR I NFORMATION AND A D P LACEMENT C ONTACT : M ELISSA M OODY J OURNAL OF H YPERTENSION L IPPINCOTT W ILLIAMS & W ILKINS 351 W EST C AMDEN S TREET B ALTIMORE , MD 21201-2436 T ELEPHONE : 1-800-269-4339 OR 410-528-4098 F AX : 410-528-4452 E- MAIL : melissa.moody@wolterskluwer.com B ONUS D ISTRIBUTION : March Issue: American College of Cardiology Convention Issue November Issue: ...

The American Society of Hypertension , Inc. 148 Madison Avenue, Fifth Floor, NY, New York 10016-6700 • (212) 696-9099 • Fax (212) 696-0711 www.ash-us.org Embargoed For Release: Thursday, May 18, 2006 - 12:01am EDT Contacts: Mel Granick Susan Rood 212-884-0660/0650 212-884-0643/0650 mgranick@chamberlainpr.com srood@chamberlainpr.com ASH Press Room May 16-20 212-261-6184 Study of American Indians Indicates Racial and Gender Disparities in Development of Hypertension Findings from The Strong Heart Study Examined at 21 st Annual Scientific Meeting of American Society of Hypertension NEW YORK, May 18, 2006 – Data from the largest epidemiological study of cardiovascular disease (CVD) and its risk factors in the American Indian community may indicate racial differences in the development of hypertension and that ...

Annual number of hospitalizations among persons with pulmonary hypertension , United States, 1980–2000 Source: CDC, National Hospital Discharge Survey. Facts on Pulmonary Hypertension • Pulmonary hypertension is a rare lung disorder in which the blood pressure in the pulmonary artery rises far above normal levels, usually with no apparent reason. • Symptoms include chronic fatigue, shortness of breath (dyspnea), chest pain (angina), palpitations, fainting, swollen ankles and legs (edema), and fluid in the abdomen (ascites). These are also symptoms for other diseases such as congestive heart failure; therefore, physicians should rule out other diseases before making a diagnosis of pulmonary hypertension . • Pulmonary hypertension may develop after pregnancy, valvular heart diseases, chronic thromboembolic disease, lung diseases, liver diseases, sleep–disordered ...

Hypertension program HeaLtH Hero netWorK, inC. WWW.HeaLtHHero.Com The focus of the Hypertension Program is to monitor and educate patients on self-management behaviors. It includes medication reminders, an educational curriculum about medications–effects/side effects, the impor- tance of taking medications as ordered by the physician, and medication compliance. It reinforces dietary compliance, and instructs on behavior modification and lifestyle adjustments. The program also includes instruction on dietary guidelines, hypertension and alcohol, and weight management. Patients are also taught the importance of activities and given tips for blood pressure and weight measurement. Each daily session ends with an affirmation or fun trivia question. Program oVErVIEW Disease Process Blood pressure measurement * Name for high blood pressure Definition of hypertension Symptoms ...

HEALTH HERO NETWORK, INC. WWW.HEALTHHERO.COM This co-morbid program was developed by blending information from the Hypertension and the Diabetes Programs. The focus of the program is to monitor and educate patients on self-management behaviors. It includes medication reminders, an educational curriculum about medications-effects/side effects, and information on the importance of taking medications as ordered by the physician. It reinforces dietary compliance, instructs on behav- ior modification and lifestyle adjustments, activity, dietary guidelines, and gives tips for blood pressure measurement. The program also includes monitoring of blood glucose levels, dietary guidelines, foot care, and the treatment for hypo- and hyper- glycemic events. It also emphasizes the prevention of complications, preventative care activity, and psychosocial factors affecting the patient and caregiver(s). Patients are taught the signs ...

Hypertension and CHroniC obstruCtive pulmonary disease program HealtH Hero netWorK, inC. WWW.HealtHHero.Com This co-morbid program was developed by blending information from the Hypertension and the Chronic Obstructive Pulmonary Disease (COPD) Programs. The focus of the program is to monitor and educate patients on self-management behaviors. It includes medication reminders, an educational curriculum about medications– effects/side effects, and information on the importance of taking medications as ordered by the physician. It rein- forces dietary compliance, instructs on behavior modification and lifestyle adjustments, activity, dietary guidelines, and gives tips for blood pressure measurement, and medication delivery methods including inhalers. It also includes information on the prevention of complications, oxygen safety and usage, activity and psychosocial factors affecting the patient and caregiver(s). ...

Please visit us online at: http://aha.medcareers.com Or visit Hypertension online at: http://hyper.ahajournals.org F OR I NFORMATION AND A D P LACEMENT C ONTACT : J ENNIFER W ILLIAMS H YPERTENSION Journal of the American Heart Association L IPPINCOTT W ILLIAMS & W ILKINS 351 W EST C AMDEN S TREET B ALTIMORE , MD 21201-2436 T ELEPHONE : 1-800-528-1843 OR 410-528-4049 F AX : 410-528-4452 E- MAIL : jennifer.m.williams@wolterskluwer.com B ONUS D ISTRIBUTION : ...

J Ayub Med Coll Abbottabad 2006;18(1) FREQUENCY OF HYPERTENSION IN STROKE PATIENTS PRESENTING AT AYUB TEACHING HOSPITAL Jehangir Khan, Attique-ur-Rehman, Ashfaq Ali Shah*, Asif Jielani** Department of Medicine and *Ophthalmology, Ayub Medical College and Teaching Hospital and **Institute of Nuclear Medicine, Oncology & Radiotherapy, Abbottabad Background; Stroke is a frequent medical problem occurring in patients with hypertension and other risk factors. The objective of this study was to find the frequency of hypertension as important risk factor in stroke patients presenting at Medical 'B' unit of Ayub Teaching Hospital, Abbottabad from November 2003 to January 2005. Methods: Patients who clinically presented with features of stroke and then confirmed on C.T scan were included in this study. Other underlying risk factors were diabetes mellitus, smoking, cardiovascular disease ...

Dietary Approaches to Stop Hypertension (DASH) Hypertension is another name for high blood pressure. Blood pressure is the force exerted on artery walls when the heart is beating and when it is at rest. The higher number is the "Systolic" pressure and is the pressure exerted on artery walls when the heart is in the contracting phase. The lower number is the "Diastolic" pressure and is the pressure exerted on artery walls when the heart is in the resting phase. High blood pressure is a silent killer. If left unchecked, it can cause permanent damage, resulting in kidney failure, heart attack or stroke. Blood pressure is recorded in the form of a fraction with the higher number on the top and the lower number on the bottom. Blood pressure is considered high if the upper number (systolic pressure) is above 140 and the bottom number (diastolic pressure) is above 90 and stays there. High blood pressure (HBP) ...

Living Healthy with Hypertension What is Hypertension and Why Should it be Treated? Abstract : Approximately one in three Americans has hypertension . Do you know what to do if you are one of them? Hypertension means high blood pressure. Blood pressure is the force of blood against blood vessel walls. There are two numbers in a blood pressure reading, a top number and a bottom number. For example 120/80. The top number, known as the systolic blood pressure, represents the force of blood against blood vessel walls when the heart beats. The bottom number, known as the diastolic blood pressure, represents the force of blood against blood vessel walls when the heart is at rest. One or both of these numbers may be elevated. If either of the numbers remains elevated over time (over 139 systolic or 89 diastolic) then you have high blood pressure or hypertension . However, in people with diabetes ...

hypertension 1581 Kidney Disease and Its Leading Causes: Diabetes and Hypertension A Brown-Bag Presentation by Robert Beallo, M.D. Sponsored by LBNL Health Care Facilitator Program March 31, 2005 Perseverance Hall The Real Epidemics in Our Community: Hypertension , Diabetes, and Obesity Epidemic: a disease or condition which is highly prevalent in a community or large geographical area. High blood pressure : affects approximately 25% of people in the United States. Obesity : affects approximately 30% of people in the United States. Diabetes : affects approximately 8% of people in the United States. High Blood Pressure/ Hypertension What is hypertension (HTN): a blood pressure reading more than 140/90 about 25% of U.S. ...

American Journal of Hypertension www.ajh-us.org Recruitment Advertising Rate Card Effective January 2006 Updated: 4/28/06 PUBLISHER Elsevier 1600 John F. Kennedy Blvd., Suite 1800 Philadelphia, PA 19103-2899 Tel: 215-239-3714 | Fax: 215-239-3734 Web:www.ajh-us.org EDITORIAL The American Journal of Hypertension , a peer-reviewed journal provides a forum for scientific inquiry of the highest standard in the fields of hypertension and related cardiovascular disease. The journal publishes articles on basic science, molecular biology, clinical and experimental hypertension , cardiology, epidemiology, pediatric hypertension , endocrinology, neurophysiology, and nephrology. and nephrology. Authors are invited to submit previously unpublished, original clinical or experimental research articles, special communications, review articles and ...

Hypertension in Children and Adolescents GREGORY B. LUMA, M.D., and ROSEANN T. SPIOTTA, M.D., Jamaica Hospital Medical Center Family Medicine Residency Program, New York, New York T he prevalence and rate of diagnosis of hypertension in children and adolescents appear to be increas- ing. 1 This is due in part to the increasing prevalence of childhood obesity as well as growing awareness of this disease. There is evidence that childhood hyperten- sion can lead to adult hypertension . 2 Hyper- tension is a known risk factor for coronary artery disease (CAD) in adults, and the pres- ence of childhood hypertension may con- tribute to the early development of CAD. Reports show that early development of ath- erosclerosis does exist in children and young adults and may be associated with childhood hypertension . ...

Please go to www.phassociation.org/medical/cd.asp to request your complimentary copy or check the box on the reply card found at the front of the journal. The production of this CD-ROM was supported by Grant Number Purchase Request (PR)# HCL33-2005-23060 and Contract Award # 254-2005-M-13200 and Purchase Request (PR)# HCL33-2004-09925 and Contract Award # 200-2004-M-10076 from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the Pulmonary Hypertension Association and do not neces- sarily represent the official views of the Centers for Disease Control and Prevention. The distribution of this CD-ROM is being made possible by an unrestricted educational grant from Myogen, Inc. This companion piece to the Fall issue of Advances in Pulmonary Hypertension assists with diagnosis of pulmonary hypertension and is an invaluable ...

Harvard-MIT Division of Health Sciences and Technology HST.071: Human Reproductive Biology Course Director: Professor Henry Klapholz HST 071 IN SUMMARY PREGNANCY INDUCED HYPERTENSION Classification of Hypertensive Disorders of Pregnancy o Gestational hypertension (6-7%) Onset of HTN without proteinuria after 20wks of gestation with resolution to baseline by 12wks postpartum o Preeclampsia (5-8%) Hypertension plus proteinuria 140/90 on two occasions six hours apart 0.3 gm/dl in 24hrs or 1+ on urine analysis o Chronic hypertension (3-5%) HTN prior to pregnancy Gestational HTN which does not resolve within 12 wks of delivery o Superimposed preeclampsia (25% of CHTN) Chronic HTN plus new onset proteinuria or other signs or symptoms of preeclampsia ACOG Jan. 2002 Figure removed due to copyright restrictions. Please see: Berg, ...

Canadian Chair in Hypertension Prevention and Control ICRH contact - Arun Chockalingam E-mail: achockalingam@mrl.ubc.ca Tel: 604-806-8932 The Canadian Institutes of Health Research (CIHR) via its CIHR/Rx&D Research Program, Aventis Pharma Inc. (a member of the sanofi-aventis Group), the Canadian Hypertension Society (CHS), and the Canadian Coalition for High Blood Pressure Prevention and Control (CCHBPPC), with help from Health Canada and the Heart and Stroke Foundation, have developed a funding mechanism for a senior health care professional: the first-ever Canadian Chair in Hypertension Prevention and Control. The mission of the Chair will be to focus on improving awareness, prevention and control of hypertension by interaction with federal and provincial health care agencies, health care providers and the community at large. The ...

Unrestricted Data and Business Rules – Established Hypertension Indicator Set Author Paul Amos Version No 8.0 Version Date 15-Mar-2006 New GMS Contract QOF Implementation Dataset and Business Rules - Established Hypertension Indicator Set Page 2 Unrestricted Hypertension ruleset_v8.0 Version date: 15-Mar-2006 Amendment History: Version Date Amendment History Draft 0.3 21-Jun-2003 From Peter Horsfield 1.0 24-Sep-2003 Standard Headers and footers Applied and set to approved. 1.1 03-Nov-2003 Added headers and footers to Version 0.4 received from Pete Horsfield on 03/11/03. 2.0 12-Nov-2003 Amended following 4 Country review 3.0 20-Jan-2004 Amended following January READ Code Release 4.0 04-Feb-2004 Amended following 4 Country, ...

Unrestricted Data and Business Rules – Established Hypertension Indicator Set Author Paul Amos Version No 8.0 Version Date 15-Mar-2006 New GMS Contract QOF Implementation Dataset and Business Rules - Established Hypertension Indicator Set Page 2 Unrestricted Hypertension ruleset_R4_v8.0 Version date: 15-Mar-2006 Amendment History: Version Date Amendment History 0.1 09-Jul-2004 From Peter Horsfield. Extracted from July Read Code Release. Contains Read v0 only. 1.0 27-Sep-2004 Amended following 4 Country Review 1.1 18-Jan-2005 Amended following January READ Code Release 1.2 21-Jun-2005 Amended following 4 Country review 2.0 21-July-2005 Signed off following 4 Country review 2.1 21-July-2005 Amended following July 2005 Read Code ...

TESTIMONY OF MR. JACK STIBBS CHAIRMAN OF THE BOARD PULMONARY HYPERTENSION ASSOCIATION ON BEHALF OF THE PULMONARY HYPERTENSION ASSOCIATION 801 ROEDER RD, SUITE 400 SILVER SPRING, MD 20910 (301) 565-3004 REGARDING FISCAL YEAR 2007 APPROPRIATIONS FOR CDC, NIH AND HRSA PRESENTED TO THE HOUSE LABOR-HHS-EDUCATION APPROPRIATIONS SUBCOMMITTEE MARCH 29, 2006 SUMMARY OF FY 2007 RECOMMENDATIONS: • $250,000 within the Centers for Disease Control and Prevention for a pulmonary hypertension awareness and education program. • A 5% increase for the National Heart, Lung and Blood Institute and the establishment of “Specialized Centers of Clinically Orientated Research” on Pulmonary Hypertension at the Institute. • $25 million for the Health Resources and Services Administration’s “Gift of Life” Donation Initiative. ...

Heart and Stroke Foundation of Ontario Social Determinants of Hypertension Special Competition Application APPLICATION CHECKLIST 2006/2007 COMPLETE AND FORWARD THIS SHEET WITH YOUR APPLICATION Name of Applicant Date A. CONTENTS OF COMPLETE APPLICATION The original and EIGHT (8) photocopies of the full application must be assembled and submitted to the Heart and Stroke Foundation of Ontario (HSFO). Page ii - Names of suitable referees. Page 4 - Details of the grant proposal. Page 1 - All six (6) items must be completed. Page 5 - Ethics forms and name of administrative officer. Page 2 - Summary of the proposal. Page 6 - Budget page, double-checked for mathematical accuracy. Page 3 - Structured lay summary of the research proposal completed. CV - Complete and attach a copy of Common CV for the principal investigator and each co-applicant. ...

ISHIB Website ISHIB 100 Auburn Avenue, Suite 401 Atlanta, GA 30303 404-880-0343 ph 404-880-0347 fax ISHIB HYPERTENSION ACADEMY 2006 Friday, June 23, 2006 8:30 am – 12:30 pm Join the experts as they present this complimentary program offering a clinical update on hypertension and related disorders. The course, which will be delivered by noted specialists in hypertension , will serve as an authoritative source for the most recent information on hypertension and its treatment. This four-hour session will give participants the opportunity to study and discuss current research on effective strategies for the management and treatment of hypertension , the use of diuretics and other antihypertensive agents, and, approaches to treating hypertensive patients with chronic kidney disease. The course provides up- to-date, novel approaches for the prevention and treatment of hypertension , which may be accompanied ...

Pulmonary Hypertension Association (PHA) The Pulmonary Hypertension Association’s (PHA) mission is to seek a cure for pulmonary hypertension and provide hope for the pulmonary hypertension community through support, education, advocacy, and awareness. Beginning in 1990, three patients asked the National Organization for Rare Disorders (NORD) to help them locate other patients with PH. From its humble beginnings around a “kitchen table,” PHA has grown to incorporate over 6,000 members. In May of 1990, PHA’s first newsletter, Pathlight, was created to serve the PH Community with timely and relevant news. PHA currently produces two unique newsletters mailed to all PHA members, as well as an electronic newsletter, informing them about organizational activities, medical developments, and other news affecting the PH community. PHA offers online tools at www.phassociation.org to connect people ...

Pulmonary Hypertension Treatments Although there is no cure for PH, there are several treatments available, and patients have more options than ever before. Calcium channel blockers, or CCBs, have been used to treat PH since the 1980s and slow the influx of calcium ions into muscle cells, so the cells and arteries stay relaxed. This lowers blood pressure. In PH patients, the goal is to lower the pressure inside the lungs. When the blockers work, the change is usually immediate and dramatic; patients who respond well to these pills see an improvement in symptoms, a reduction in mean PAP, and cardiac output that stays the same or improves. At most, only one out of five PH patients will be a true “responder”. In most patients, CCBs have little effect and can often make the disease worse. CCBs are less likely to help patients with PH triggered by another disease. Adverse effects include ...